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Abstract 
Raman spectroscopy is rapidly moving from an experimental technique for the analysis of 
biological molecules to a tool for the real-time clinical diagnosis and in situ evaluation of the oral 
tissue in medical and dental research. The purpose of this study is to identify various applications 
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of Raman spectroscopy, to evaluate the contemporary status and to explore future directions in 
the field of dentistry. Several in-depth applications are presented to illustrate Raman 
spectroscopy in early diagnosis of soft tissue abnormalities. Raman spectroscopy allows to 
analyze histological and biochemical composition of biological tissues. The technique not only 
demonstrates its role in the disclosure of dysplasia and malignancy but also in performing guided 
biopsies, diagnosing sialoliths, and assessment of surgical margins. Raman spectroscopy is used 
to identify the molecular structures and its components to give substantial information about the 
chemical structure properties of these molecules. In this paper, we acquaint the utilization of 
Raman spectroscopy in analyzing the soft tissues in relation to dentistry. 
Keywords 
Raman spectroscopy, Dental tissue, Oral soft tissue analysis 
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Introduction 
Soft tissue is an accumulation of cells and extracellular matrix. Cells of any tissue carry 
out specific function within the organ. On this basis, all the organs, structures and other elements 
of a multicellular organism can be assigned to a specific tissue in the body. Study of a tissue is 
termed as histology and its pathology is defined as histopathology, which is regarded as a gold 
standard to study properties of natural tissue. In last few decades, histopathology has improved 
significantly with the invent of digital pathology or whole slide imaging, which involves digital 
image capturing at different wavelengths and later computer analysis. Later introduced electron 
microscopy and fluorescence microscopy significantly elevated our knowledge in terms of 
structure and function of tissue. However, all these techniques need considerable specimen 
preparation for analysis. Furthermore, there is limited approachability of the label to the target, 
insufficient binding specificity and a poor stability (1, 2). 
Quest for new techniques to identify structural and functional properties has been the 
focus of attention and as a result a number of new analytical techniques have been added to the 
armory of both clinical and non-clinical researchers. Raman and Fourier Transform Infrared 
(FTIR) spectroscopic techniques have been used to study chemical structural properties of cells, 
fresh and fixed tissues, normal and diseased tissues, and drug interactions with the tissue 
allowing to identify chemical pathway of these interactions. Both these techniques are 
complimentary to each other, sensitive and rapid (3-12). Raman spectroscopy is based on the 
Raman scattering or Raman effect i.e., inelastic dissipating (approximately 1 in 106 to 1 in 108 
photons) of monochromatic visible (400-700nm) or laser (700-850nm) or UV light (below 
270nm), brought on by discrete changes in eminent light, above and underneath the wavelength 
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of the incident photons because of the vibrational frequencies of the bio-molecules that constitute 
the tissue (11-19). 
The utilization of Raman spectroscopy has progressed into the various fields of science 
and physics. It is a valuable tool in biomedical field making it possible to extract the data from 
the spectra using a number of spectral diagnosis methods. The spectral bands of biological and 
synthetic tissues are specific to particular chemical groups that can be recognized and analyzed. 
Innovation of fiber optic-probes has made possible to examine tissue without sectioning (20-24). 
Benefits of Raman spectroscopy are non-invasive, non-destructive, requires minimal or no 
sample preparation, thus helping in faster diagnosis. Based on its other advantages, which 
include linear response to chemical concentrations, easier spectral/band analysis, sharp spectral 
signatures, weak water scattering and reproducible results, Raman spectroscopy is widely 
applied in biomedicine as a device for diagnosis of tissue lesions, examination of blood 
segments, investigation of single cells and even non-contact monitoring technology in various 
biomedical fields (25-45). 
Furthermore, Raman spectroscopy is a helpful tool in estimating the cancer margins, 
which assist the surgeon in conservative excision of the cancer lesion without any remnants. Its 
high spatial and spectral resolution demarcates the exact location and borders of the lesion even 
to an extent of single molecule identification (46). Spatially Offset Raman Spectroscopy (SORS) 
and Transmission Raman Spectroscopy (TRS) assures diagnosis even in deeply located lesions 
(47). Raman spectroscopy, by adopting the Gaussian classification method, can efficiently 
differentiate deeply seated oral carcinomas (48). Latest modifications in the probe design has 
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allowed Stimulated Raman Spectroscopy (SRS) examination of superficial tissues in hollow 
tracts of the human body, such as oral mucosa (49). 
Raman spectroscopy can also be used to reveal the molecular framework of proteins, 
lipids, DNA and other biological molecules, providing a ³molecular fingerprint´ (50). In 
particular, the molecular fingerprint in the range of 1800 to 100cm1 which coincide with the 
spectra of biochemical structures provides the data of specific biochemical structures 
(biochemical signatures) of the tissue, providing an opportunity to distinguish between tissue 
types. Additionally, spectral collection can be performed in vitro or in vivo without disturbing 
the cellular environment, and it has the capacity of detecting minimal alterations in the 
biochemical composition of living cells to produce a diagnostic molecular fingerprint of the 
target tissue without provoking photo- induced cellular damage (45, 51). 
The use of Raman spectroscopy for discriminating the malignant and the pre malignant 
lesions from the normal site has been studied in various locations, which include brain, breast, 
gastro-intestinal tract, gynecologic tract, larynx, skin and oral cavity (52-58). This article audits 
the uses of Raman spectroscopy in dentistry based on its distinguishable spectral characteristics 
to analyze healthy and pathological oral soft tissues. By recognizing the relevant peaks (Table 1), 
this article serves as an aide for further studies focused on application of Raman spectroscopy on 
oral soft tissues. 
Path Toward Clinical Implications of Raman Spectroscopy 
Technology Development 
The technology and methodology had to be developed to collect and interpret the Raman 
spectra, for a considerable period of time, as tissue fluorescence and lack of applicable, sensitive 
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instrumentation were major obstacles for the development of Raman spectroscope for the clinical 
applications (12). Nevertheless, the field of Raman spectroscopy has seen tremendous advances 
over the last thirty years. The difficulty of tissue fluorescence, has been overcome to the large 
extent by the accessibility of instruments operating within the near-IR region. Fluorescence from 
biomolecules, cells and tissues can be avoided by laser excitation within the deep UV excitation 
and the robust auto fluorescence background caused by optical elements was overcome by 
increasing the excitation of laser (11, 12) 
With the arrival of nanotechnology and its application in medicine, Surface Enhanced 
Raman Spectroscopy (SERS) has emerged to unravel the challenges encountered with Raman 
spectroscopy. SERS improves the Raman signal by 109-1014 times (45). In addition, the robust 
fluorescence background is greatly reduced, due to the absorption of molecules on the metal 
nanoparticles, there by resonance enhancement of particular molecular vibrations can be 
achieved (5). The SERS is a promising technique for analyzing biomolecules, as well as 
biomarkers, such as, deoxyribonucleic acid (DNA), cells, viruses and microorganisms for early 
detection of oral cancers (11). It can combat inherently weak signal from saliva by using surface 
enhanced approach with gold particles (10). 
Applications of Raman Spectroscopy in Normal Oral Soft Tissues 
The oral cavity is accepted to have an impact on systemic wellbeing. Different studies 
have demonstrated that oral cavity shows an important part in giving forecasts, furthermore the 
anticipation of fundamental systemic wellbeing (33, 59). 
Raman spectroscopy helps in the screening of asymptomatic patients to recognize the 
concealed primary or otherwise malignant lesions and furthermore to evaluate the hidden risk of 
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developing cancer. There are considerable differences between well developed and synchronized 
histological assessment, such as, WHO dysplasia grading system and the Ljubljana grading 
system, which are based on the same architectural and cytological changes (60). Unfortunately, 
there is no simple relationship or overlapping between the classification systems, figures 1a --c 
show the areas of similarity in the classification systems but also the problems arising when 
matching the WHO categories moderate and severe dysplasia with the Ljubljana category 
atypical hyperplasia Figure 1d [60]. Figure 1a-d shows the development of oral cancer over a 
period of time; and recognition of severe dysplasia starts with greater than two-thirds of the 
epithelium showing architectural disturbance with associated cytological atypia. However, 
architectural disturbance extending into the middle third of the epithelium with sufficient 
cytological atypia is upgraded from moderate to severe dysplasia. Raman spectroscopy may be 
an effective technique to accurately detect the pre-cancerous lesions of the oral cavity, the 
mucosa collected is inhomogeneous consisting of different layers and histological structures. 
Cals FLJ et al reported on the Raman spectroscopic analysis of histopathological structures in 
oral mucosa (61). Raman spectroscopy also offers an attractive potential to achieve dependable 
and reproducible signals from various oral sites, among subjects of diverse races and gender 
(37). 
Near Infrared (NIR) Fourier Transform (FT) Raman spectroscopy presented in the mid-
80s minimized and in some cases diminished the issue of fluorescence, by using the substrates 
made of CaF2 and BaF2 and test debasement, which is chosen over visible light excitation. This 
particular property is responsible for the potential in vivo tissue diagnosis, because NIR 
wavelengths could penetrate deeper into tissue with less absorption by surrounding tissue 
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components (2, 12). In recent years, NIR-Raman spectroscopy has shown favorable results for 
the exact diagnosis and evaluation of the disease progression in various organs, especially in the 
oral cavity which helps to evaluate the resection margins during excision of any intraoral 
malignancy (62, 63). It has the ability to penetrate the tissue for several millimeters, creating a 
³diagnostic window´ a distinguishing feature to diagnose sub-mucosal lesions (21). A number of 
researchers have used this approach to analyze biological tissue mounted on CaF2 windows by 
Raman spectroscopy (2, 12). 
Wu et al reported on the use of FT-Raman spectroscopic for the analysis of oral tissues. 
Well defined strong C-H stretching bands were observed at 2925 and 2959 cm1 and the C = O 
vibration of triglycerides at 1740-1745 cm1 in normal tissues, in contrast to the weak C-H 
stretching band and C = O band in the malignant tissue. These results demonstrated an effective, 
convenient, accurate and noninvasive method of cancer diagnosis (64). de Veld et al (2005) 
investigated the biopsy tissues of 37 human oral mucosa lesions. Complete auto-fluorescence 
pictures and spectra were recorded from 20 micron section areas. Study evaluated the possible 
relationship between spectral shape and lesion type or cell layer. Auto-fluorescence pictures 
demonstrated high intensities of keratin layers and connective tissue, yet scarcely any for the 
epithelium. This study showed clear variations between different cell layers, concluding the high 
sensitivity and specificity of Raman spectroscopy for demonstrating biochemical changes (58). 
Guze et al performed multivariate analysis on 25 Caucasian and 26 Asian patients at 7 specified 
sites within the oral cavity to study the dependability and reproducibility of Raman spectroscopy 
among distinctive races and sex. Study showing unique spectra based on location of tissue was 
attributed to keratin levels in the respective tissues. However, no significant spectral association 
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was observed for different subject ethnicity or sex. They also illustrated, the potential use of 
Raman spectra for in vivo cancer diagnosis (6). 
Lo et al. applied Raman spectroscopy to Ex Vivo Produced Oral Mucosa Equivalent 
(EVPOME) to see the cellular activity. They observed a positive correlation with amide I (1655 
cm1)/phenylalanine (1004 cm1) with a negative linear regression (R2 > 0.95), particularly on 
the 14th and 21st culture day (65). To study the epithelium at different levels, it was sliced into 
various thicknesses and was found that the Raman peak intensities of amide I, C--H, amide III 
and C--OH decrease as the keratinocytes mature. This aspect also determined the relationship 
between the maturities of the keratinized oral mucosa and various components between the 
epithelial and connective tissue cells. They observed a relative increase in intensity of the 1254 
cm1 peak in the amide III region and the right shift of the wavelength in the amide I region at 
deeper levels. This shows the favorable application of Raman spectroscopy for quantitatively 
monitoring and evaluating the maturity of EVPOME. 
Bergholt and Huang also used Raman spectroscopy to study oral soft tissues at different 
anatomical locations. Distinctive spectra related to the biochemical variations at different 
anatomical sites of the oral cavity were observed within the spectral range of 1800--800 cm1 
(66). They used specially designed fiber-optic Raman probe with a ball lens for real-time, in vivo 
Raman measurements at different areas in the oral cavity (i.e. inner lip, attached gingiva, the 
floor of the mouth, dorsal and the ventral surface of the tongue, hard and soft palate and buccal 
mucosa). The semi quantitative non-negativity-constrained elements (i.e. hydroxyapatite, keratin, 
collagen, DNA, and oleic acid) and partial least squares-discriminant analysis (PLS-DA) were 
employed to estimate the importance of inter-anatomical variability. This study reveals 
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significant inter-anatomical variability and suggested that histological and morphological 
attributes of different sites have a significant impact on the in vivo Raman spectra, and thus 
various sites can be categorized with an overall sensitivity and specificity of 85%. Their work on 
Characterizing variability in in-vivo Raman spectra of different anatomical locations in the upper 
gastrointestinal tract toward cancer detection was of interest as this study was part of an ongoing 
nationwide cancer screening program aiming at early diagnosis and treatment of upper GI 
malignancies run by the Singapore gastric cancer epidemiology, clinical and genetic program. 
This demonstrated that Raman spectroscopy can be very successfully employed to differentiate 
between actin, collagen, DNA, histones, and triolein) which are used for biochemical modeling 
of other cancerous tissues as well. Bergholt et al further reported that high quality in vivo Raman 
spectra can routinely be acquired from different anatomical locations or lesion sites within the 
esophagus and gastric in real-time (<0.5 s) under multimodal imaging (WLR, NBI, and AFI) 
guidance during clinical endoscopic examinations. [see Figure 2]. They also reported that to 
characterize the spectral contribution from important Raman active tissue constituents (e.g., 
proteins, DNA, and lipids) semi-quantitative modeling was based on five spectra of actin, 
collagen type I, DNA, histones, and triolein) [see Figure 3], which may also be valuable in 
modelling other types of cancer from different anatomical sites. 
Applications of Raman Spectroscopy in Oral Cancer 
The alteration of healthy tissue into a malignant lesion is a gradual process which 
involves changes at the molecular level, thereby altering the morphology and tissue architecture. 
Cancer is an unusual growth of cells, which might conceivably attack the neighboring normal 
cells if left untreated. Despite the fact that there are more than 200 different varieties of cancer, 
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the malignancy of epithelial layer accounts for 85% (67, 68). Carcinomas of the head and neck 
are one of the most common cancers, of which the majority originates from the oral cavity most 
commonly involving the buccal and labial mucosa, tongue, the floor of the mouth, gingiva, lips, 
periodontium and oropharynx (69, 70). The standard techniques of evaluation of any oral lesion 
are thorough clinical examination followed by assessing its potential in progressing to oral 
cancer (71, 72). Oral cancers are often diagnosed at the terminal stages associated with extensive 
histopathological changes, hence regardless of treatment there is a more chance of recurrence 
(73, 74). 
In spite of the advancement in surgery and radio-chemotherapy, no huge enhancements 
with respect to patient survival could be seen in the most recent decades (75). It has been 
demonstrated that the survival rate relates profoundly with the disease stage (76). Inappropriate 
methods of cancer screening and diagnosis results in delayed identification of the disease (77). 
Thus, early diagnosis is required to avoid life threatening complications (66). Conventional 
diagnostic methods such as visual inspection, biopsy and histopathology inherit inter examiner 
variations (78). Human and economic constraints, lack of significant clinical presentation, patient 
reluctance to undergo biopsy, sampling mistakes, obligatory invasiveness and tissue loss 
associated with biopsy are the variables influencing the delay and errors of the diagnostic process 
(79-81). This leads to the increasing interest in finding alternative diagnostic techniques such as 
cytological techniques, histomorphometric analysis, cytomorphometry, DNA cytometry and 
immunocytochemical analysis, optical coherence tomography, high resolution micro-endoscopy 
(HRME) and polymerase based diagnostic kits (82, 83). 
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These bio-optical approaches could overcome the diagnostic restraints on the basis of a 
familiar principle that, when tissues are illuminated with light, the derivative of this optical 
spectrum will give the data about the molecular or chemical composition and the surface 
characteristics of the exposed tissue (38). These light- based imaging of the tissues detects even 
minimal changes in cell microanatomy (nuclear/cytoplasmic ratio), DNA Ploidy and 
quantification of nuclear DNA content, redox status, expression of specific biomarkers, tissue 
architecture and composition, chemical changes (mineralization), vascularity/angiogenesis and 
perfusion (78, 84, 85). Tissue transformation from normal to malignant state brings about 
changes in the morphology at molecular levels, which has an impact on the absorption and 
reflection of light. Delivery of a specific wavelength of light to both the normal and abnormal 
tissue is kept as a standard spectroscopic data and any abnormal tissue of unknown origin can be 
analyzed and compared with the available pattern that is histologically proved to be normal and 
abnormal tissue thus aiding in diagnosis (86). The detectable changes at molecular level are 
perfect for recognition of early changes in the lesion tissues, evaluation of lesion margins, the 
likely presence of subclinical margins, monitoring of the existing noninvasive lesions and brisk 
examination of at risk population (87). Various spectroscopic techniques have their own spectral 
patterns of different tissues with varying normal, precancerous and malignant changes. These 
specific patterns help in assessing the stage of carcinogenesis, (86) and this collected information 
gives a scope for characterization of the tissue by a number of bio-optical methods, of which 
Raman spectroscopy is one of the most optimal method to be discussed in this particular paper, 
which would provide detailed biochemical information that may be used to detect initial stages 
of malignancy. The Raman bands noticed during this maneuver that help in diagnosis are mainly 
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relevant to proteins, possibly collagen (tyrosine, tryptophan, and phenylalanine), nucleic acids, 
and lipids. The developments in the application of Raman spectroscopy by the use of near 
infrared excitation decreased the autofluorescence of biological specimen, whereas, the fiber-
optic Raman probes contributed in molecular fingerprinting and in vivo analyses. Currently, 
automated Raman systems are being employed in rapid evaluation of the biological tissues in 
vivo, very often within 5 sec or less (4, 6, 21, 30). 
Malini et al in 2006 (24) analyzed the competence of Raman spectroscopy to segregate 
216 pre-malignant, malignant, inflammatory and normal tissue samples from the oral cavity. In 
spite of having accessibility to oral cavity, the majority of lesions are diagnosed in last stages of 
the illness, to be more precise unfortunately around 60 percent of them were in T3 or T4 by the 
time they were diagnosed. This indicates a critical impact on the survival rate, which is 40% 
according to the World Health Organization (69) or less than 60% according to American Cancer 
Society (39). In this scenario, Raman spectroscopy may prove to be a useful adjunctive tool for 
early diagnosis, which is of paramount importance to the long-term survival of patients. 
The oral cavity is easily approachable in a clinic setting and would be a perfect model for 
the development of a Raman probe for cancer detection. Raman spectroscopy explicit the 
progressions in molecular composition and molecular adaptation that happen in tissue amid 
carcinogenesis. Recent advancements in fiber-optic test innovation empower its application as an 
in vivo procedure (68) with the exception of its use in parotid tumors because of the impedance 
of the superficial skin and subcutaneous tissues, for which only ex vivo is advised. Modern 
advancements in Raman spectroscopic instrumentation and data management analysis have 
prompted challenging results concerning the spectroscopic diagnosis of cyto-pathological 
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samples. Furthermore, the freedom of labeling and staining has allowed the recognition of 
circulating malignant cells in body fluids (88). Recent studies reveal that Raman spectroscopy 
disclosed promising results in identification of pathologies of head and neck regions (10, 21). 
Studies have shown the practicality of the use of Raman spectroscopy in identification of oral 
squamous cell carcinomas (24, 61), the malignant changes of which correspond to the increase in 
DNA and proteins (73). Raman spectroscopy is sensitive to a wide variety of proteins, lipids and 
nucleic acids and has been applied in the analysis of various normal and diseased tissues of the 
human body including the bladder, hypopharynx, breast and testicles; and also in the evaluation 
of anti-cancer drugs at cellular level. (89-94). 
Stone et al., evaluated utilization of Raman spectroscopy in diagnosing malignancy of 
larynx (56). They utilized homogenous biopsy specimens with distinctly characterized 
pathological findings for histopathological analysis. Study included 7 histologically normal 
healthy samples, 4 displaying dysplasia, 4 with carcinoma and 5 to 12 spectra were obtained 
from each specimen. Results showed apparent variations in the spectra in the range of 950 to 850 
cm1, and 1350 to 1200 cm1. The later peaks are precisely associated with protein compliance 
and C-H bond in nucleic acid bases and the relative intensity of the nucleic acid peak rises with 
the progress of malignancy. Linear discriminant analysis showed greater extent of certainty of 
disease in comparison to the empirical peak ratio methods. Results achieved from cross-
validation of the discriminant model revealed prediction specificities of 94%, 91%, and 90% and 
sensitivities of 83%, 76%, and 92% for healthy, dysplastic and carcinoma samples respectively. 
Bakker Schut et al., investigated the effectiveness of Raman spectroscopy for in vivo 
classification of normal and cancerous tissue of rats (28). Dysplasia in the palate of rats was 
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incited by the topical use of a cancer-causing agent (4-nitroquinalone 1-oxide). Normal and 
dysplastic tissues were collected in vivo by a fiber-optic test which was coupled to a Raman 
spectrometer with a NIR excitation laser. Raman spectra obtained from these tissues using 
integration tie of 100s were tested with the in vivo spectra obtained using signal collection times 
of 10s, to categorize the tissues as normal, low and high grade dysplastic. The high grade 
dysplastic tissues were distinguished with a sensitivity and specificity of 100%. 
Venkatakrishna et al., evaluated 25 biopsy samples and 24 surgically sectioned samples 
of which 37 were squamous cell carcinoma and the remaining normal and performed principal 
component analysis of 140 spectra to derive statistically significant quantitative information 
about the spectral components of the malignant and normal tissues. These spectral characteristics 
thus obtained helps in the screening of the population, decision of surgical boundaries, follow up 
for regression and recurrence and also progress during chemotherapy (95). 
A study was conducted by Krishna et al., on the formalin fixed normal and carcinoma 
tissues of oral squamous epithelium stored at room temperature for a period of two months. 
Raman spectroscopic analysis was done on both the epithelial and the sub epithelial regions of 
these tissue samples. In the epithelial region of both the normal and the malignant layer, the 
spectra showed drastic changes in the biochemical structure and no differences were seen in the 
sub epithelial layer. Spectral change was attributed to the protein composition, structural change 
and increase in the protein content. The discrimination of normal, malignant and sub epithelial 
tissues was well appreciated with this technique and was significantly conclusive in validation of 
formalin fixed tissues for optical analysis (96). 
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Lau et al., obtained Raman spectra of normal, benign, and cancerous laryngeal tissues 
and reported chemical differences that are present between these different tissues (21). A total of 
47 laryngeal samples including normal tissue, carcinoma and squamous papilloma (n = 18, 13, 
and 16 respectively) were studied with signal acquisition times (SAT) around 1 and 30 seconds. 
Multivariate investigation was performed to decide the diagnostic capacity of Raman spectra in 
comparison to the normal histology. Great quality of spectra were acquired with 5-second SAT. 
Spectral peak examination demonstrated prediction sensitivities of 89%, 69%, and 88%, and 
specificities of 86%, 94%, and 94% for normal tissue, carcinoma, and papilloma respectively. 
Oliveira et al., used FT-Raman spectroscopy to evaluate the changes in the vibrational 
bands of normal, dysplastic and squamous cell carcinoma tissues. They reported that detection of 
weak Raman signals from tissue samples was easy by FT-Raman due to fluorescence 
suppression. In this study 7, 12-dimethybenzanthracene, a toxin was applied daily in the oral 
pouch of 21 hamsters for 14 weeks to bring about carcinogenic changes, followed by collection 
of normal squamous cell carcinoma tissues from the oral region and analysis using a 1064nm 
Nd:YAG laser as an excitation source. Around 123 spectral sequences were obtained and were 
grouped into normal and malignant tissue by performing statistical analysis using principal 
component analysis (PCA) and was also classified using Mahalanobis distance approach. 
Considerable differences were seen between the normal and malignant spectra, which was 
attributed to the composition and structural alteration in protein and increased protein content in 
malignant epithelium. An algorithm was based on PCA with sensitivity of 91% and 100%, and 
specificity of 69% and 55% in the training and prospective groups respectively. It was also 
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interpreted that principal component analysis had the potential for classifying Raman spectra and 
could be used for detection of dysplastic and malignant oral lesion (29). 
Li et al., analyzed squamous cell carcinoma (SCC) of oral mucosa using near infrared 
Raman spectroscopy (25). Study was done on 10 normal mucosa, 20 SCC and 30 oral 
leukoplakia tissues to compare with the characteristic band obtained in previous studies. 
Classification and diagnostic models were done on Gaussian radial basis function support vector 
machine, and efficacy and validity of the algorithm was evaluated. Increased peak intensity in 
the wave number range of 2200 to 500cm1 indicated high contents of DNA, protein and lipid in 
SCC, which also elucidated the high proliferative activity in the cell. It was observed that the 
discrepancy between OLK and SCC was higher when correlated to that of the difference between 
normal and SCC. The Gaussian radial basis function support vector machine presented effective 
ability in grouping and modeling of normal and SCC, and the specificity, sensitivity and 
accuracy were 100%, 97.44% and 98.81% respectively. This algorithm also showed good ability 
in grouping and modeling of OLK and SCC, with specificity of 95%, sensitivity of 86.36 and 
accuracy of 96.30%. It was concluded that NIR-Raman spectroscopy could delineate the 
biochemical differences in oral normal, OLK and SCC and establish a diagnostic model with 
good accuracy. 
Guze et al., in 2012 employed micro-Raman spectroscopy to describe the 
molecular/spectral differences between healthy and squamous cell carcinoma (SCC) in oral 
mucosa (97). Samples confirmed by histopathological examination as squamous cell carcinomas 
in various grades of malignancies (SCCs) were collected from the lateral aspect of the tongue. 
Normal tissue from contralateral intraoral site was also collected. All the collected samples were 
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flash-frozen and cut into two sections, one specimen being examined histologically and the other 
micro-Raman (confocal) spectroscopy. Freshly flashed-frozen tumor and matched normal tongue 
specimens were studied from 4000 to 300 cm1 spectral range. The spectral resolution used was 8 
cm1, spatial resolution was 1.0ȝP DQG WKe excitation wavelength was 515nm. They observed 
statistically significant spectral differences between healthy and malignant samples in relation to 
the origins of specific signals within the cells of each tissue type. They discovered specific cell 
surface protein spectral biomarkers at 1583 cm1. 
Devpura et al. (98) performed principle component and discriminant functional analysis 
to study normal, invasive squamous cell carcinoma and carcinoma in situ of the tongue after the 
samples were placed in formalin and dewaxed. The dewaxing of the fixed tissues is of utmost 
importance, as contamination with dust particles or wax as a result of inappropriate de-waxing 
affects the spectrum leading to false information and discouraging results. As wax contributes to 
the fingerprint region of the spectra, it interferes with amide I, keratin, nucleic acid and amide III 
compartments and prevent their expression, which has the most sensitive information in 
biological tissues. Mian et al (99) reported that in spectroscopic studies it is extremely important 
to completely eliminate wax in order to acquire comprehensive expression of vital components, 
which are of diagnostic significance. Complete removal of wax is essential to achieve spectral 
contributions from amide I, keratin, amide III, nucleic acid (DNA) and phenylalanine. These 
regions were hindered in spectra of tissues kept in xylene for up to 28 minutes whereas their 
expressions were recorded clearly in the spectrum analysed after 30 minutes in xylene. Wax 
contamination in Raman spectra obstructs the information regarding chemical composition in 
biological tissues. A phenylalanine contribution at 1002 cm1 is expressed in the spectrum of 
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tissue section kept in xylene for 30 minutes, which was absent in pure wax spectrum (figure 4). 
Therefore, it is extremely important to eliminate wax in order to achieve accurate results. Mian et 
al (99) demonstrated that to eliminate wax contamination from 20µm thick tissue sections a 30 
minutes treatment in xylene is required. 
The goal of Devpura et al (98) study was to explore the effectiveness of Raman 
spectroscopy for early diagnosis and identify possible biomarkers of head and neck squamous 
cell carcinoma. They compared Raman spectroscopy findings with the results of histological 
examination and detected an accuracy of 89% for invasive squamous cell carcinoma, 91% for 
carcinoma in situ and normal tissues. This study also showed escalation of tryptophan values and 
declining of keratin in squamous cell carcinoma. 
Lloyd et al. in 2013 conducted multivariate analysis to discriminate benign, primary and 
secondary malignancies in lymph nodes of head and neck, in which they collected 103 lymph 
node samples from 23 patients undergoing surgery for incredulous lymph nodes (100). Five 
pathological conditions defined by histopathology were studies which included benign reactive 
nodes, Hodgkins and Non-Hodgkins lymphoma, metastasis from squamous cell carcinoma and 
adenocarcinomas. Raman spectra were obtained with 830nm excitation laser and analyzed using 
principal component linear and partial least square discriminant analysis. The results showed 
sensitivity and specificity of 90 and 86% in two group models, above 78 and 89% for three-
group models and above 81 and 89% for all groups. 
Knipfer et al. examined 12 ex-vivo oral cancer samples using principal component and 
linear discriminant analysis after being subjected to Shifted Excitation Raman Difference 
Spectroscopy (SERDS). They compared the results of Raman spectroscopy and histopathology. 
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Mean of 72 spectra obtained from 3 physiological tissue sites and pathological lesions were 
examined (101). Spectra of malignant and benignant tissues were differentiated based on spectral 
features of proteins, lipids and nucleic acids and the results showed a classification error of 9.7%. 
Guze et al. analyzed the tissue based molecular signatures of Raman spectra to 
differentiate the premalignant and malignant condition of normal mucosa and benign lesions, 
with the aim to overcome the subjective errors associated with histopathology. 18 patients with 
histologically diagnosed oral disease were studied and compared with Raman spectroscopy along 
with the contra-lateral healthy areas. Principal component and multivariate analysis were used to 
compare the whole spectra instead of single Raman peaks. The results showed a clear variation 
between premalignant and malignant lesions and healthy and benign lesions (39). 
Singh and Krishna performed a study using fiber optic probe along with a Raman 
spectroscopy on histologically confirmed tumor of buccal mucosa and noticed higher lipid and 
lower protein bands in normal tissues, whereas, higher protein bands were noticed in tumor 
tissues. Biochemical estimation also showed similar results with high protein-to-lipid or protein 
to phospholipid ratio in tumors in comparison to normal tissues. The results were statistically 
significant at the intensity of 1440 cm1 (lipid) and 1450 and 1660 cm1 (protein). They 
concluded that, the findings of curve deconvolution and biochemical evaluation associate well 
and proposed that spectral features are the trademark of underlying biochemical tissue 
composition (102). Krishna et al also conducted a pilot study for differential diagnosis of 
cancerous and precancerous lesions of oral cavity in a clinical setting using in-vivo Raman 
spectroscopy (30). They studied 28 healthy volunteers and 171 patients with various oral lesions. 
Raman spectra was obtained from multiple different sites of normal and abnormal oral mucosa 
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and were categorized histopathologically as healthy, oral squamous cell carcinoma, oral 
submucous fibrosis and leukoplakia. The spectra was subjected to probability based multivariate 
statistical algorithm and found an accuracy of 85%, 89%, 85% and 82% in classifying the oral 
tissues. 
Daniel et al. created pseudo color Raman maps from the Raman micro images of 
cancerous and noncancerous samples (67). They found that, the maps correlated with the 
histopathological image of the same tissue section with 98.9% accuracy. Study proposed a 
classification model to distinguish healthy and cancerous oral tissues based on the Raman 
spectral features. The results of this study also showed decreased presence of glycogen, lipids, 
and proteins, such as, tryptophan and phenylalanine in all the cancerous samples. Whereas, the 
nucleic acid (DNA/RNA) content was found to be less in normal samples compared to the 
cancerous samples (67). Shyam Sunder et al. also differentiated oral tumors of different grades 
using relative intensities of bands associated with lipids and proteins. They noticed an increase in 
proteins and decrease in lipids in malignant and normal tissues respectively (104). These results 
were in par with Mahadevan - Jensen et al study suggesting that Raman spectrum can effectively 
distinguished to the molecular and structural changes associated with neoplastic transformation 
(55). 
Singh et al. evaluated the potential capability and efficiency of Raman spectroscopy in 
identifying early premalignant conditions (105). Spectra were obtained from suspected 
premalignant lesions, contralateral normal tissue and cancer lesion sites from subjects with oral 
cancers; and healthy subjects of the same age group with and without tobacco consumption 
habits. Study employed fiber optic probe in conjunction with Raman spectrophotometer, and 
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results were analyzed using principal component and linear discriminant analysis. They 
concluded that the premalignant conditions could be discriminated from contralateral normal and 
abnormal sites, as well as from healthy controls, which further supported the application of 
Raman spectroscopy in diagnosing oral tumors. 
Singh et al also reported on malignancy associated metachronous and synchronous 
secondary tumors in oral cavity (106). Low survival rates in cancer afflicted individuals were 
attributed to malignancy associated changes in the uninvolved areas. This study employed 
Raman spectra to categorize five groups namely - healthy controls without any habits, healthy 
controls with tobacco habit, no cancer, cancer and contralateral normal, and cancer people 
without any habits. Spectra suggested changes in protein, lipids and DNA in pathology prone 
areas. There was a difference in the spectra obtained from healthy controls and those with habits 
and disease free, indicating that malignancy associated changes can be identified. It was 
concluded that Raman spectroscopy had the potential of identifying metamorphic changes in oral 
mucosa thus helping in early diagnosis of oral cancer. 
Lau et al distinguished normal and cancerous nasopharyngeal tissue by employing a rapid 
acquisition Raman spectrometer (107). They collected normal and malignant biopsy tissues from 
6 patients and the obtained spectra showed, reliable differences between normal and malignant 
tissue in three bands 1320 -- 1290cm-1 (P¼0.005), 1470 -- 1420cm1 (P¼0.006), and 1580 --
1530cm1 (P¼0.002). A similar study was done by Feng et al with gold nanoparticle based 
surface-enhanced Raman scattering spectroscopy by employing near-infrared laser excitation and 
concluded that amino acids decrease in cancerous conditions, whereas the nucleic acids (DNA) 
and thymine increases (108). Huang found that the combination of nanorods could be 
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advantageous instead of spherical gold colloids. They noticed that human oral cancer cells are 
kept together and arranged next to gold nanorods that were combined with antibodies against the 
epidermal growth factor receptor. The molecules located near nanorods produced an incredibly 
improved, sharp, and polarized Raman spectrum. The authors have demonstrated that these 
nanorods have the capacity to be utilized as cancer biomarkers (68). 
Application of Raman Spectroscopy on Bio-fluid Diagnostic Assays 
The investigation of bio-fluids can be used as diagnostic assays in a variety of medical 
conditions, ranging from routine blood check up to intra operative monitoring due to its easy 
accessibility, less invasiveness, and its ability to allow for repeated sampling. Body fluids 
contains biomolecules which are of diagnostic significance, but at times, in inadequate 
concentration to be estimated with Raman spectroscopy. One highly efficient way is to pre-
concentrate the protein for drop coated deposition Raman spectroscopy (DCDRS). This has been 
shown to provide a precise estimation of the concentration of protein mixtures in solutions even 
when pre-concentrated. The use of DCDRS has been exhibited in human tears indicating a 
promising tool for the measurement of both local and systemic disease biomarkers. Discovery of 
genetic and epigenetic materials arising from tumor or circulating tumor cells in body fluids 
symbolize an attractive option for quicker and non-invasive identification of early cancers (109). 
Harris et al. explored to discriminate the noncancerous and cancerous lesions by Raman 
spectroscopy using a peripheral blood sample. They collected 40 blood samples from patients 
suffering from head and neck cancers and patients with respiratory illness to be used as control 
group (110). Principal component and linear discriminant analysis achieved approximately 65% 
sensitivity and specificity for differentiating cancer and respiratory illness in samples. 
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Furthermore, when the genetic program was used to the data, an increased sensitivity and 
specificity of 75% was seen. Based on this pilot study, they concluded the possible feasibility of 
using Raman spectroscopy in screening and diagnosis of cancers and solid tumors through a 
peripheral blood sample. However, it is premature to make any positive conclusions on the basis 
of this limited study. 
The metabolic products released into the circulatory system from cells or tissues as end 
products that alter in systemic conditions may serve as markers for that particular condition. 
Based on these markers, Sahu et al examined serum from patients suffering from oral cancer of 
buccal mucosa and tongue, and healthy patients (111). Spectral features indicate diverse 
contributions of proteins, DNA, and amino acids like Phenylalanine, Tryptophan and Trypsin, 
DQGȕ-carotene in the selected groups. Profound Raman EDQGVRQȕ-carotene were observed in 
normal patients and increased DNA and proteins were observed in cancer spectra unlike the 
phenylalanine decrease in cancer patients. Additionally, a propensity of categorizing buccal 
mucosa and tongue cancers was noticed and the study reported a diagnostic sensitivity and 
specificity of 81% and 75% in the detection of oral cancer by using 514nm excitation laser. 
Rekha et al identified the biomolecules present in the blood plasma in a clinically 
confirmed healthy normal, precancerous and cancerous groups by using 784nm laser excitation 
(112). Alternative to serum, saliva was taken into consideration by Qiu et al. in detection of oral 
cancer (113). Because 95% of the saliva is water, a surface enhanced Raman or SERS was 
utilized to identify the delicate chemical alterations in salivary samples. The uses of saliva in 
diagnosing the cancer have few advantages which include easy, painless, readily accessible, 
non-invasive, quick, and economical sample collection (114, 115). According to Olivo M the 
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peaks at 1627, 1079 and 670 cm1 have important diagnostic value and especially the peak at 
1627 cm1 provides valuable data indicating malignant changes using saliva specimens (116). 
Qiu et al. evaluated the use of saliva SERS for detection of non-invasive nasopharyngeal 
carcinoma. Analysis showed significant differences at 1448, 1270, 1134, 729, 635, 496 and 447 
cm1, which basically consist of signals related to collagen, glycogen, fatty acids, nucleic acids 
and proteins. They provided a relatively high diagnostic sensitivity, specificity and accuracy of 
86.7%, 81.3% and 83.9% respectively. The SERS peak centered at 729 cm1 demonstrates 
highest intensity in nasopharyngeal carcinoma patients indicating the amount of DNA and RNA 
in saliva due to the apoptosis of cancerous cells and tumor necrosis (114). 
Applications of Raman Spectroscopy in Other Conditions 
Sialoliths associated with the salivary glands and their ductal system are calcified masses 
usually composed of calcium phosphate (hydroxyapatite: [Ca10(PO4)6(OH)2)] with traces of 
magnesium and carbonate. These mineral components have been studied by various methods 
including high-resolution electron microscopy and X-ray diffraction. Kinoshita et al. explained 
in detail the precise formation of sialolith by analyzing the actual distribution of organic (amide 
III) and inorganic (phosphate) content within the sialolith with the help of Raman spectroscopy 
(117). The sialolith from the submandibular gland was used for the study. They observed the 
spectral peaks of amide III and phosphate at 1265 and 960 cm1 respectively (118). 
Yan et al. proposed a technique to apply Raman spectroscopy to examine the differences 
in the spectra between Warthin¶V tumor, pleomorphic adenoma, and normal parotid gland tissues 
(41). Along with this, they setup the diagnostic model of the Raman spectra of parotid gland 
neoplasms by using support vector machine (SVM) with Gaussian radial basis function. SVM 
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was used to examine the different Raman spectra obtained from these various histopathological 
tissues. Results showed difference in the spectral region of 1800 to 800cm1 demonstrating the 
biochemical alteration at the molecular level among the histopathological tissues. In comparison 
with normal parotid gland tissues, there was rise in the content of proteins, lipids and DNA in 
pleomorphic adenoma. Where as in Warthin tumor the content of DNA was increased but 
proteins and lipids were decreased. Yan et al. also demonstrated research to detect label-free 
blood serum by using surface-enhanced Raman spectroscopy (SERS) and support vector 
machine (SVM) in the pre-operative evaluation of parotid gland tumors (117). 
In addition to the in vivo applications, Raman spectroscopy offers numerous open doors 
for the advancement of other sensitive diagnostic tools, quick labeling of pathogenic micro-
organisms and tumor grade typing (5,12). Raman spectroscopy empowers to identify the most 
frequent pathogenic microorganisms in the circulatory system infections in patients admitted in 
intensive care units (ICU). Very quick labelling and testing the susceptibility, and quick 
reporting paves the way for the selection of most appropriate antibiotics in cases of infection, and 
the most suitable therapy in early stages of cancer (12). 
Summary 
Raman spectroscopy is rapidly becoming an established technique for the chemical 
structural analysis of soft tissues, as a number of clinical biopsies and non-clinical samples 
(tissue engineered samples) can be analyzed with minimal sample preparation and furthermore 
the drug interactions with the tissue can also be studies in detail. In addition to its use as a 
diagnostic technique, it can be an excellent tool to monitor the progression of disease or to 
identify the resistant and sensitive nature of the drug employed to treat cancer. Raman 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 Sh
eff
iel
d]
 at
 02
:18
 24
 M
ay
 20
16
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 
27 
spectroscopy had shown promising results with the added advantage of being a non-invasive, 
non-destructive tool along with providing a real time diagnosis and due to the enormous leap in 
using Raman spectroscopy for diagnosis, it is at a stage to perform systematic clinical trials for 
diagnosing a dysplastic condition in a very early stage of cancer development. 
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Table 1: Raman peaks and the characteristic assignments related to soft tissue analysis 
Raman shift (cm1) Peak assignment References 
2925-2959 C-H stretching band for normal tissues 64 
1740-1745 C = O vibration of triglycerides for normal tissues 64 
1698--1699  Amide I 116 
1662 Nucleic acid 113 
1655 Amide I 65 
1619 Tryptophan 113 
1607 C = C band in Phenylalanine or Tyrosine 116 
1583 Cell surface protein spectral biomarker 97 
1541--1551 C-N stretching, Amide II 116 
1450-1660 Protein 102 
1448 CH2 bending mode of collagen 113 
1441--1445 CH2, CH3 bending in proteins and lipids 116, 102 
1440 Lipid 102 
1541--1551,1441--1445 Guanine in DNA, Tryptophan in proteins 116 
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1368--1373, 1607 
1336 Nucleic acid 113 
1326--1329 CH vibration in DNA/RNA, CH2 twisting in lipids 116 
1270 C-C waver mode of fatty acids 113 
1265 Amide III 118 
1261--1264 CH bending in lipids 116 
1254 Amide III 65 
1200-1350 
Protein compliance and C-H bond in nucleic acid 
bases 
56 
1140 Carotenoids 116 
1134 Glycogen 113 
1127 C-C stretching in lipids, C-N stretching in D-Mannos 116 
1094 C-N stretching mode in D-Mannos 116 
1084 C-C stretching mode in phospholipids 116 
1004 Phenylalanine 65 
1003 Phenylalanine 113 
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960 Phosphate 118 
933 C-C stretching mode, C-&ĮKHOL[LQSURWHLQV 116 
812 L-Serine 113 
744--747 Thymine in DNA 116 
729 C-H in plane bending mode of adenine 113 
723--727 Hypoxanthine 116 
635 Tyrosine 113 
543--548 S-S disulfide stretching in Proteins 116 
496 D-mannose 113 
292--296 Au-S band 116 
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Figure 1(a); Photomicrograph showing area of increased epithelial thickness together with 
hyperkeratosis: mild dysplasia (WHO) or parabasal hyperplasia (Ljubljana) [Reproduced with 
permission] [60] 
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Figure 1b; Photomicrograph showing blunt and elongated epithelial ridges and cytonuclear 
atypia confined to the lower epithelial half: moderate dysplasia (WHO) or atypical hyperplasia 
(Ljubljana). [Reproduced with permission] [60] 
  
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 Sh
eff
iel
d]
 at
 02
:18
 24
 M
ay
 20
16
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 
50 
 
Figure 1c; Photomicrograph showing epithelial alterations involving the entire epithelial 
thickness: severe dysplasia (WHO) or atypical hyperplasia (Ljubljana). [Reproduced with 
permission] [60] 
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Figure 1d; Oral epithelial dysplasia classification system: predictive value, utility, weaknesses 
and scope for improvement (WHO) (Ljubljana) [Reproduced with permission] [60] 
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Figure 2; (a) In vivo mean Raman spectra ±1 SD of normal (antrum, body, and cardia) and 
neoplastic gastric tissues. (b) In vivo mean Raman spectra ±1 SD of the normal (distal, middle, 
and proximal) and neoplastic esophageal tissues. Note that the mean Raman spectra are vertically 
shifted for better visualization. [Reproduced with permission from SPIE, J. Biomed. Opt. 2011; 
16(3):037003-037003-10. doi:10.1117/1.3556723] (119) 
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Figure 3: The five basis reference Raman spectra (i.e., actin, collagen, DNA, histones, and 
triolein) are used for biochemical modeling of esophageal and gastric tissue. [Reproduced with 
permission from SPIE, J. Biomed. Opt. 2011; 16(3):037003-037003-10. 
doi:10.1117/1.3556723] (119) 
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Figure 4; Raman spectra of 20 µm tissue sections after de-waxing in xylene for increasing 
lengths of time (2 to 30 minutes). (99) 
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